Results 131 to 140 of about 317,764 (294)
Travel medicine, travel-related diseases and required vaccines [PDF]
, 2020 George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020Introduction.
Popovici, Diana-Maria
core
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Impact of the COVID-19 pandemic on travel medicine services in Taiwan, 2019–2022
Travel Medicine and Infectious DiseaseBackground: The COVID-19 pandemic profoundly disrupted international travel and travel medicine services worldwide. Few studies have examined nationwide trends.
Szu-Hsuan Huang +4 more
doaj +1 more source
, 2012 Background. Health-care professionals can help travelers by providing accurate pre-travel counseling for mosquito- transmitted diseases such as malaria, yellow fever, and dengue fever.
黃獻樑;邱泰源;黃國晉;程劭儀;姚建安;李龍騰 +1 more
core
MITF maintains genome stability in nonmelanocyte lineages
Molecular Oncology, EarlyView.MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
BackgroundThe Boston Area Travel Medicine Network surveyed travelers on travel-related health problems.MethodsTravelers were recruited 2009\u20132011 during pre-travel consultation at three clinics.
core
Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization
Molecular Oncology, EarlyView.In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu +13 more
wiley +1 more source
Allergic reaction following the consumption of exotic fried insects in a traveler visiting Thailand
Travel Medicine and Infectious Disease, 2023 Sakarn Charoensakulchai +4 more
doaj +1 more source